AI’s Impact on Publisher Traffic: A Growing Divide
Search referral traffic to small publishers has plummeted, with a 60% drop over the past two years, according to exclusive data from Chartbeat reported by Axios . This decline is nearly three times steeper than that experienced by larger publishers, signaling a growing disparity in the digital media landscape.
The Traffic Collapse: A Breakdown by Publisher Size
Chartbeat’s analysis, which tracks traffic across thousands of websites globally, segmented publishers by size to reveal the extent of the issue. Mid-sized publishers (10,000 to 100,000 daily page views) saw a 47% decrease in search referrals, while large publishers (over 100,000 daily page views) experienced a 22% decline .
Search and Discover Traffic Declines
Between December 2024 and December 2025, page views from Google Search fell by 34%, and Google Discover referrals decreased by 15%, according to the Chartbeat data . This coincides with a broader trend of declining search traffic observed in late 2025 .
The Rise of AI Chatbots – A Limited Offset
While ChatGPT referrals grew by over 200% during the same period, they still account for less than 1% of all publisher page view referrals . The growth in chatbot traffic has not been sufficient to compensate for the losses from search.
How Larger Publishers Are Adapting
Larger publishers are demonstrating an ability to offset search losses by diversifying their traffic sources. They are seeing growth in direct and internal traffic, as well as increased referrals from email and apps . This aligns with a broader industry trend of investing in owned channels .
AI Referral Engagement: A Content-Type Divide
Chartbeat’s data reveals a significant difference in how users interact with content referred from AI chatbots depending on the type of website. News and media sites receive the highest volume of page views from AI referrals, but experience the lowest engagement per article . This suggests users are primarily using news citations in chatbots for quick fact-checks or context, rather than in-depth reading. Conversely, “utilitarian sites” – those offering advice on topics like health or gardening – receive fewer referrals but higher engagement per article.
About Chartbeat
Chartbeat provides analytics tools to publishers and has been tracking website traffic for nearly two decades . Its data covers thousands of websites globally, with a particular focus on news and media publishers. For the purposes of this data, small publishers average 1,000 to 10,000 daily page views, medium publishers range from 10,000 to 100,000, and large publishers exceed 100,000 .
Why This Matters
The decline in search referral traffic disproportionately impacts smaller publishers, who have fewer resources to develop alternative traffic streams. The breakdown of data by publisher size highlights the need for a nuanced understanding of the challenges facing different segments of the digital media industry. The value of AI referrals also varies significantly depending on the type of content published.
Keep reading
- Staff UX Content Designer, YouTube Creators Monetization at Google
- OpenAI Acquires AI Camera Startup Glass Imaging for Over $300M Ahead of Mystery Gadget Launch
- Why Bridges Have Small Gaps in the Road (daybreakwire.com)
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)